These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 19097893)

  • 1. Positive allosteric modulators of the metabotropic glutamate receptor subtype 4 (mGluR4). Part II: Challenges in hit-to-lead.
    Williams R; Niswender CM; Luo Q; Le U; Conn PJ; Lindsley CW
    Bioorg Med Chem Lett; 2009 Feb; 19(3):962-6. PubMed ID: 19097893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Positive allosteric modulators of the metabotropic glutamate receptor subtype 4 (mGluR4): Part I. Discovery of pyrazolo[3,4-d]pyrimidines as novel mGluR4 positive allosteric modulators.
    Niswender CM; Lebois EP; Luo Q; Kim K; Muchalski H; Yin H; Conn PJ; Lindsley CW
    Bioorg Med Chem Lett; 2008 Oct; 18(20):5626-30. PubMed ID: 18793851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery, characterization, and antiparkinsonian effect of novel positive allosteric modulators of metabotropic glutamate receptor 4.
    Niswender CM; Johnson KA; Weaver CD; Jones CK; Xiang Z; Luo Q; Rodriguez AL; Marlo JE; de Paulis T; Thompson AD; Days EL; Nalywajko T; Austin CA; Williams MB; Ayala JE; Williams R; Lindsley CW; Conn PJ
    Mol Pharmacol; 2008 Nov; 74(5):1345-58. PubMed ID: 18664603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 3-Benzyl-1,3-oxazolidin-2-ones as mGluR2 positive allosteric modulators: Hit-to lead and lead optimization.
    Duplantier AJ; Efremov I; Candler J; Doran AC; Ganong AH; Haas JA; Hanks AN; Kraus KG; Lazzaro JT; Lu J; Maklad N; McCarthy SA; O'Sullivan TJ; Rogers BN; Siuciak JA; Spracklin DK; Zhang L
    Bioorg Med Chem Lett; 2009 May; 19(9):2524-9. PubMed ID: 19328692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3-(Imidazolyl methyl)-3-aza-bicyclo[3.1.0]hexan-6-yl)methyl ethers: a novel series of mGluR2 positive allosteric modulators.
    Zhang L; Rogers BN; Duplantier AJ; McHardy SF; Efremov I; Berke H; Qian W; Zhang AQ; Maklad N; Candler J; Doran AC; Lazzaro JT; Ganong AH
    Bioorg Med Chem Lett; 2008 Oct; 18(20):5493-6. PubMed ID: 18812259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and SAR of a novel positive allosteric modulator (PAM) of the metabotropic glutamate receptor 4 (mGluR4).
    Williams R; Johnson KA; Gentry PR; Niswender CM; Weaver CD; Conn PJ; Lindsley CW; Hopkins CR
    Bioorg Med Chem Lett; 2009 Sep; 19(17):4967-70. PubMed ID: 19640716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. mGluR4 positive allosteric modulators with potential for the treatment of Parkinson's disease: WO09010455.
    East SP; Gerlach K
    Expert Opin Ther Pat; 2010 Mar; 20(3):441-5. PubMed ID: 20180624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological and molecular characterization of the positive allosteric modulators of metabotropic glutamate receptor 2.
    Lundström L; Bissantz C; Beck J; Dellenbach M; Woltering TJ; Wichmann J; Gatti S
    Neuropharmacology; 2016 Dec; 111():253-265. PubMed ID: 27590915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent progress in the development of mGluR4 positive allosteric modulators for the treatment of Parkinson's disease.
    Lindsley CW; Niswender CM; Engers DW; Hopkins CR
    Curr Top Med Chem; 2009; 9(10):949-63. PubMed ID: 19754407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluorinated 9H-xanthene-9-carboxylic acid oxazol-2-yl-amides as potent, orally available mGlu1 receptor enhancers.
    Vieira E; Huwyler J; Jolidon S; Knoflach F; Mutel V; Wichmann J
    Bioorg Med Chem Lett; 2009 Mar; 19(6):1666-9. PubMed ID: 19233648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Putative mGluR4 positive allosteric modulators activate G
    Abulwerdi G; Stoica BA; Loane DJ; Faden AI
    Neurochem Int; 2020 Sep; 138():104770. PubMed ID: 32454165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advances in the drug discovery of metabotropic glutamate receptor 4 (mGluR4) activators for the treatment of CNS and non-CNS disorders.
    Célanire S; Campo B
    Expert Opin Drug Discov; 2012 Mar; 7(3):261-80. PubMed ID: 22468956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and synthesis of novel heterobiaryl amides as metabotropic glutamate receptor subtype 5 antagonists.
    Kulkarni SS; Newman AH
    Bioorg Med Chem Lett; 2007 Apr; 17(7):2074-9. PubMed ID: 17336520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and SAR of a mGluR5 allosteric partial antagonist lead: unexpected modulation of pharmacology with slight structural modifications to a 5-(phenylethynyl)pyrimidine scaffold.
    Sharma S; Rodriguez AL; Conn PJ; Lindsley CW
    Bioorg Med Chem Lett; 2008 Jul; 18(14):4098-101. PubMed ID: 18550372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The discovery of VU0652957 (VU2957, Valiglurax): SAR and DMPK challenges en route to an mGlu
    Panarese JD; Engers DW; Wu YJ; Guernon JM; Chun A; Gregro AR; Bender AM; Capstick RA; Wieting JM; Bronson JJ; Macor JE; Westphal R; Soars M; Engers JE; Felts AS; Rodriguez AL; Emmitte KA; Jones CK; Blobaum AL; Conn PJ; Niswender CM; Hopkins CR; Lindsley CW
    Bioorg Med Chem Lett; 2019 Jan; 29(2):342-346. PubMed ID: 30503632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Co-operative binding assay for the characterization of mGlu4 allosteric modulators.
    Poutiainen P; Kil KE; Zhang Z; Kuruppu D; Tannous B; Brownell AL
    Neuropharmacology; 2015 Oct; 97():142-8. PubMed ID: 26025660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel selective allosteric modulator potentiates the activity of native metabotropic glutamate receptor subtype 5 in rat forebrain.
    O'Brien JA; Lemaire W; Wittmann M; Jacobson MA; Ha SN; Wisnoski DD; Lindsley CW; Schaffhauser HJ; Rowe B; Sur C; Duggan ME; Pettibone DJ; Conn PJ; Williams DL
    J Pharmacol Exp Ther; 2004 May; 309(2):568-77. PubMed ID: 14747613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, evaluation, and radiolabeling of new potent positive allosteric modulators of the metabotropic glutamate receptor 2 as potential tracers for positron emission tomography imaging.
    Andrés JI; Alcázar J; Cid JM; De Angelis M; Iturrino L; Langlois X; Lavreysen H; Trabanco AA; Celen S; Bormans G
    J Med Chem; 2012 Oct; 55(20):8685-99. PubMed ID: 22992024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Challenges in the development of mGluR5 positive allosteric modulators: the discovery of CPPHA.
    Zhao Z; Wisnoski DD; O'Brien JA; Lemaire W; Williams DL; Jacobson MA; Wittman M; Ha SN; Schaffhauser H; Sur C; Pettibone DJ; Duggan ME; Conn PJ; Hartman GD; Lindsley CW
    Bioorg Med Chem Lett; 2007 Mar; 17(5):1386-91. PubMed ID: 17210250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and evaluation of a series of heterobiarylamides that are centrally penetrant metabotropic glutamate receptor 4 (mGluR4) positive allosteric modulators (PAMs).
    Engers DW; Niswender CM; Weaver CD; Jadhav S; Menon UN; Zamorano R; Conn PJ; Lindsley CW; Hopkins CR
    J Med Chem; 2009 Jul; 52(14):4115-8. PubMed ID: 19469556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.